Get An Even Better Deal On ICPT Than Director Benatti Did
May 23, 2019 at 09:58 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 14, Intercept Pharmaceuticals Inc's Director, Luca Benatti, invested $100,200.00 into 1,200 shares of ICPT, for a cost per share of $83.50..
